Diabetes linked to longer-term antiplatelet therapy and higher ischaemic risk: Insights from the EPICOR Asia Study

Diabetes linked to longer-term antiplatelet therapy and higher ischaemic risk: Insights from the EPICOR Asia Study

2020.12.07

The EPICOR Asia (Long-Term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients in Asia) registry is a prospective, observational study of 12,922 patients with acute...


Impact of the COVID-19 pandemic on inpatient management and outcomes of AMI

Impact of the COVID-19 pandemic on inpatient management and outcomes of AMI

2020.11.30

In light of the rapid spread of coronavirus disease 2019 (COVID-19) worldwide, researchers in China conducted a study to provide insights into the in-hospital management and outcomes of acute...


Lower-dose DOAC regimen related to improved survival in patients with established atherosclerosis

Lower-dose DOAC regimen related to improved survival in patients with established atherosclerosis

2020.11.23

Antithrombotic/anticoagulation effects of direct oral anticoagulants (DOACs) are dose dependent. However, recent observations suggest that administering lower-dose DOACs may better protect against...


Recent study strengthens the case for smoking cessation interventions in ACS patients

Recent study strengthens the case for smoking cessation interventions in ACS patients

2020.11.16

The prevalence of smoking among patients with acute coronary syndrome (ACS) is high in China. However, there remains a lack of clinical interventions for smoking cessation as part of formal ACS...


CTA improves positive rate of ICA in low- to moderate-risk NSTEMI patients

CTA improves positive rate of ICA in low- to moderate-risk NSTEMI patients

2020.11.09

A Chinese study was conducted recently to investigate whether computed tomography coronary angiography (CTA) can safely and effectively reduce the number of invasive coronary angiographies (ICAs) and...


Real-world data showing a shift in preference towards NOACs and aspirin-free antiplatelet strategy

Real-world data showing a shift in preference towards NOACs and aspirin-free antiplatelet strategy

2020.11.02

A recent study investigating ‘real-world’ trends of antithrombotic treatment strategies in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI)...


Ticagrelor improves LV remodelling in post-PCI STEMI patients

Ticagrelor improves LV remodelling in post-PCI STEMI patients

2020.10.26

Ticagrelor showed superiority to clopidogrel for left ventricular (LV) remodelling after reperfusion of ST-segment elevation myocardial infarction (STEMI) with primary percutaneous coronary...


Modified HEART score effective as a predictive tool for MACE in Asian patients

Modified HEART score effective as a predictive tool for MACE in Asian patients

2020.10.19

Chest pain is the most common potentially life-threatening presentation to the emergency department (ED). Additionally, the diagnosis of acute coronary syndrome including its risk stratification and...


Higher WBC counts linked to worse clinical outcomes among post-PCI patients receiving ticagrelor monotherapy

Higher WBC counts linked to worse clinical outcomes among post-PCI patients receiving ticagrelor monotherapy

2020.10.12

Increased white blood cell (WBC) counts, which may reflect degree of inflammation, at the time of index procedure may attenuate the anti-ischaemic effects of ticagrelor monotherapy observed in...


Early DES-ISR and left ventricular systolic dysfunction associated with MACE

Early DES-ISR and left ventricular systolic dysfunction associated with MACE

2020.10.05

The mechanism and characteristics of early and late drug-eluting stent in-stent restenosis (DES-ISR) have not been fully defined. Particularly, it remains unclear whether outcomes among these...